3 completed, 1 terminated. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Terminated 1 |
Follow StaphVax: new trials by email Literature Review of StaphVax trials Research Report on StaphVax
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease Staph aureus types 5 and 8 conjugate vaccine, placebo - Staphylococcal Infections, Chronic Kidney Failure | Phase 3 | Terminated | Nabi Biopharmaceuticals | 99 | 2005-08-01 | 2008-01-04 |
| StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery S. aureus Types 5 and 8 Capsular Polysaccharide Conjugate, placebo - Staphylococcal Infections | Phase 3 | Completed | Nabi Biopharmaceuticals | 67 | 2005-04-01 | 2008-01-04 |
| Evaluation of Manufacturing Lot of StaphVAX S. aureus Type 5 & 8 Capsular Polysaccharide Vaccine - Staphylococcal Infections, Chronic Kidney Failure | Phase 3 | Completed | Nabi Biopharmaceuticals | 65 | 2005-03-01 | 2008-01-04 |
| StaphVAX in Cardiovascular Surgery Patients S. aureus Type 5 & 8 Capsular Polysaccharide Conjugate, placebo - Staphylococcal Infections, Cardiovascular Diseases | Phase 3 | Completed | Nabi Biopharmaceuticals | 120 | 2004-06-01 | 2008-01-04 |
Staphylococcal Infections (4) · Kidney Failure, Chronic (2) · Cardiovascular Diseases (1) · Cross Infection (1)
United States (3) · United Kingdom (1)
Matt Hohenboken, MD, PhD (3) · Preston Holley, MD (1)